According to the announcement, completion of the placing of 31,468,000 new H shares under a general mandate took place on December 2, 2025. The newly issued H shares represent approximately 7.27% of the enlarged H share class and 6.25% of the enlarged total share capital. The placing price was set at HK$98.80 per H share, resulting in net proceeds of about HK$3,055.71 million and an effective issue price of roughly HK$97.11 per share after deducting related expenses.

The announcement indicates that the newly allocated shares have been placed to at least six independent placees, none of whom has become a substantial shareholder. Overall, total issued shares increased from 471,933,373 to 503,401,373.

As disclosed, approximately 75% of the net proceeds from this transaction is earmarked for investments or acquisitions of upstream and downstream businesses, with another 15% allocated to business operation and development. Around 10% of the funds will be used to repay amounts under existing credit facilities. All unutilized net proceeds are expected to be fully deployed within two years.